Yatigen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-10-2024
- Paid Up Capital ₹ 0.10 M
as on 23-10-2024
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 59.92%
(FY 2023)
- Profit -13.35%
(FY 2023)
- Ebitda -145.69%
(FY 2023)
- Net Worth -33.01%
(FY 2023)
- Total Assets -5.93%
(FY 2023)
About Yatigen Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arvind Sharma and Manju Sharma serve as directors at the Company.
- CIN/LLPIN
U24299UP2016PTC088190
- Company No.
088190
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2016
- Date of AGM
31 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Yatigen Lifesciences Private Limited offer?
Yatigen Lifesciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Yatigen Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Sharma  | Director | 07-Dec-2016 | Current |
| Manju Sharma | Director | 07-Dec-2016 | Current |
Financial Performance and Corporate Structure Insights of Yatigen Lifesciences.
Yatigen Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.92% increase. The company also saw a substantial fall in profitability, with a 13.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 33.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yatigen Lifesciences?
In 2023, Yatigen Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organo Tech Farmer Producer Company Limited
Active 9 years 28 daysArvind Sharma and Manju Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Yatigen Lifesciences?
Unlock and access historical data on people associated with Yatigen Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yatigen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yatigen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
